高流动性组盒子1蛋白质:在帕金森病中可信的治疗分子标
Ahsas Goyal1, Anant Agrawal1, Nandini Dubey1
1Department of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India.
Current pharmaceutical biotechnology
|September 6, 2023
概括
高流动性组盒1 (HMGB1) 在帕金森病 (PD) 中发挥关键作用,通过影响线粒体功能障碍,神经炎症和自. 针对HMGB1为PD提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,具有复杂的潜在机制.
- 线粒体功能障碍,神经炎症,α-synuclein聚合和自功能障碍都与PD的发病有关.
- 精确的分子路径驱动这些病理过程在PD仍然在很大程度上未定义.
研究的目的:
- 审查和整合当前关于高流动性组框1 (HMGB1) 在帕金森病中的多方面的作用的研究.
- 阐明HMGB1在PD发病和进展中的重要性.
- 在PD中确定HMGB1向治疗策略的未来研究方向.
主要方法:
- 文献综述整合了关于HMGB1参与PD病理学的研究.
- 在线粒体功能障碍,神经炎症,自和亡中分析HMGB1的调节功能.
- 综合发现,突出HMGB1在PD中的重要性.
主要成果:
- HMGB1参与调节PD的关键病理过程,包括线粒体功能障碍,神经炎症和自.
- 有证据表明,HMGB1在帕金森病的发展和进展中起着重要作用.
- 阻断HMGB1在PD临床前研究中显示出有希望的结果.
结论:
- HMGB1是帕金森病的发病过程中的关键分子参与者.
- 准HMGB1为PD管理提供了潜在的治疗途径.
- 需要进一步的研究来解决特定的治疗挑战,并优化针对PD的HMGB1向治疗方法.
相关概念视频
01:24Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
01:15Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
01:32Microtubule Associated Motor Proteins
8.1K
Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular...
8.1K
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K